ClinicalTrials.govpublic full text
Rifaximin in Fatty Liver Disease
nonalcoholic fatty liver disease, nafld, nonalcoholic steatohepatitis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 158000
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.